Dual-isotope subtraction SPECT-CT in parathyroid localization

Area of Science:

• Nuclear Medicine
• Endocrinology
• Radiology

Background:

• Primary hyperparathyroidism is often caused by parathyroid adenomas.
• Accurate preoperative localization of parathyroid adenomas is crucial for successful surgical outcomes.

Purpose of the Study:

• To evaluate the accuracy of dual-isotope subtraction single-photon emission computed tomography-computed tomography (SPECT-CT) for parathyroid adenoma detection and localization.
• To compare SPECT-CT findings with surgical pathology and clinical follow-up.

Main Methods:

• A retrospective study included 224 patients with primary hyperparathyroidism.
• Patients received iodine-123-iodide and technetium-99m-sestamibi for dual-isotope subtraction SPECT-CT.
• Imaging results were compared with pathology (115 patients) and 2-year clinical follow-up.

Main Results:

• The study analyzed 135 patients with complete follow-up data.
• Dual-isotope subtraction SPECT-CT showed 95% sensitivity and 89% specificity for adenoma detection.
• The technique achieved 94% accuracy in detection and 92% in localization.

Conclusions:

• Dual-isotope subtraction SPECT-CT is a highly sensitive and specific imaging method.
• This technique is a reliable preoperative tool for identifying and locating parathyroid adenomas in primary hyperparathyroidism.